Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Nasdaq

What 5 Analyst Ratings Have To Say About Upstart Hldgs

Within the last quarter, Upstart Hldgs (NASDAQ:UPST) has observed the following analyst ratings:

Benzinga

Expert Ratings For Coinbase Global

Within the last quarter, Coinbase Global (NASDAQ:COIN) has observed the following analyst ratings:

Benzinga

Looking Into Spartannash Company's Recent Short Interest

Spartannash Company's (NASDAQ:SPTN) short percent of float has risen 3.59% since its last report. The company recently reported that it has 2.32 million shares sold short, which is 6.64% of all regular shares that are available for trading.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Psyched: MindCure Shuts Down Operations, Novamind And MindMed Partner For Study

The psychedelics space was shaken up on the news that MindCure Health (OTC:MCURF) was shutting down operations. After a review process, the company’s board decided that MindCure’s business plan required more capital that it could gather under current market conditions, thus shutting down operations was considered the best move to preserve…

Benzinga

Analyzing Marinus Pharmaceuticals Inc's Short Interest

Marinus Pharmaceuticals Inc's (NASDAQ:MRNS) short percent of float has risen 9.74% since its last report. The company recently reported that it has 1.23 million shares sold short, which is 3.83% of all regular shares that are available for trading.

Benzinga

AC Immune: Q4 Earnings Insights

AC Immune (NASDAQ:ACIU) reported its Q4 earnings results on Tuesday, March 22, 2022 at 07:30 AM. Here's what investors need to know about the announcement. Earnings AC Immune reported an EPS of $-0.28.

Benzinga

10 Industrials Stocks Moving In Tuesday's Pre-Market Session

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Benzinga's Daily Brief On Trending Tickers For March 22, 2022: Alibaba, Nike, Tesla And More

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items possibly impacting those stocks. The data on the trending tickers is compiled from a list of most-discussed tickers on the popular Reddit forum WallStreetBets.

Benzinga

12 Consumer Discretionary Stocks Moving In Tuesday's Pre-Market Session

Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Benzinga

12 Information Technology Stocks Moving In Tuesday's Pre-Market Session

Benzinga

Why Bitcoin- And Ethereum-Related Stocks Are Trading Higher

Cryptocurrency-related stocks, including Marathon Digital Holdings Inc (NASDAQ: MARA) Riot Blockchain Inc (NASDAQ: RIOT) and Bitfarms Ltd (NASDAQ:

Benzinga

Why Jim Cramer Likes Truist Financial

On CNBC’s "Mad Money Lightning Round," Jim Cramer said PPG Industries, Inc. (NYSE: PPG) shares are down too much as the company has been hurt by raw costs, but that’s going to end finally.

Benzinga

The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Pfizer Strikes COVID-19 Pill Supply Deal, Argenx Reports Positive Late-Stage Readout

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why Upstart Shares Are Trading Lower Today

Upstart Holdings, Inc. (NASDAQ: UPST) shares are trading lower after Wedbush downgraded the stock from Neutral to Underperform and lowered its price target from $110 to $75.

Benzinga

Morning Brief: Top Stories Dominating Financial Media on Tuesday, March 22

CNBC

Benzinga

Central Banks, Bank For International Settlements Develop Digital Currencies Platform Prototype

Central banks are trying to come to terms with emerging payment technologies pioneered by tech firms. Meta Platform Inc's (NASDAQ:

Benzinga

Cannabis Industry Lender Chicago Atlantic Real Estate Finance Reports Q4 Net Income Of $4.4M On Heels Of IPO

Cannabis-focused mortgage REIT Chicago Atlantic Real Estate Finance, Inc. (NASDAQ:REFI) has reported its financial results for the fourth quarter and period ended December 31, 2021.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why This Bullish Tesla Analyst Is Reducing Their Price Target

Tesla, Inc. (NASDAQ: TSLA) shares have pulled back notably from their all-time highs in a marketwide downturn. An analyst at Jefferies is weighing in on the company's fundamental prospects and the external factors impacting its business.

Benzinga

10 Biggest Price Target Changes For Monday

Wells Fargo cut the price target on Gilead Sciences, Inc. (NASDAQ: GILD) from $70 to $63. Gilead Sciences shares rose 0.4% to $59.91 in pre-market trading.

Benzinga

AliveCor Launches Antitrust Lawsuit Against Apple Watch: Reuters

AliveCor Inc accused Apple Inc (NASDAQ:AAPL) Watch of modifying the heart rate algorithm that made it difficult for third parties to inform a user when to take an ECG or electrocardiogram, Reuters reports. The May 2021 lawsuit blamed Apple for gaining an unfair competitive edge over rivals and endangering countless AliveCor users' lives.…

Benzinga

Recap: DarioHealth Q4 Earnings

DarioHealth (NASDAQ:DRIO) reported its Q4 earnings results on Tuesday, March 22, 2022 at 06:30 AM. Here's what investors need to know about the announcement.

Benzinga

Recap: Ondas Holdings Q4 Earnings

Ondas Holdings (NASDAQ:ONDS) reported its Q4 earnings results on Tuesday, March 22, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Benzinga

Akerna Reports 61% YoY Increase In Q4 Revenue, Wider Net Loss

Akerna (NASDAQ:KERN) has reported its unaudited financial results for the quarter and year ended December 31, 2021.

Benzinga

GDS Holdings: Q4 Earnings Insights

GDS Holdings (NASDAQ:GDS) reported its Q4 earnings results on Tuesday, March 22, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

1 … 790 791 792 793

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

333 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.